Final Program

260 TUESDAY • MAY 17
P199
P200
P201
P202
P203
IL5 and IL13 -Antibodies Specifically Inhibit Asthma Features
in a Cytokine Induced Mouse Model/H. Beckert, S. Reuter, H.
Meyer-Martin, S. Korn, R. Buhl, Mainz, Germany, p.A4925
IL-33 from Inflammatory Monocytes Recruited to Lung
Contributes to HDM-Induced Airway Inflammation/H. Tashiro,
K. Takahashi, G. Kato, S. Hayashi, S. Kimura, N. Sueoka-Aragane,
Saga, Japan, p.A4926
Saccharomyces Cerevisiae UFMG 905 Modulates Cytokine
Production in the Cecum and Inhibits Lung Inflammation in an
Animal Model of Asthma/M.C. Borges, V.M. Fonseca, C. Sandy,
F.S. Martins, E.O. Vianna, Ribeirao Preto, Brazil, p.A4927
Nerve Growth Factor Promotes the Maturation and Cytokine
Release of Dendritic Cells Induced by Ovalbumin with
Low-Dose Lipopolysaccharide Via the NF-kB Pathway/P. Pan,
H. Tan, H. Li, ChangSha, China, p.A4928
Epsi-gam Attenuates Aeroallergen-Induced Early Phase
Bronchoconstriction and Late Phase Inflammation in House
Dust Mite-Sensitive Non-Human Primates /R.L. Wardle, K.M.
Gowdy, J.H. Chandler, S.W. Reece, G. Sperinde, K. Von
Loehneysen, K.B. Holley, A.F. Reid, N. Sigal, M.R. Van Scott,
Greenville, NC, p.A7875
P204 Innate Immunity Activation via Toll-Like Receptors-2/6 and -9
Agonists Suppress Viral Replication, Airway Hyperreactivity,
Mucous Metaplasia, and Eosinophilic Inflammation Associated
with Chronic Lung Disease in Mice/D.L. Goldblatt, S. Tkachman,
M. Tuvim, B.F. Dickey, Houston, TX, p.A7876
C37
THEMATIC POSTER SESSION
PULMONARY FIBROSIS
9:00 a.m. - 4:15 p.m. MOSCONE CENTER
Viewing: Posters will be on display for entire session.
Area B, Hall D (North Building, Lower Level)
Discussion: 11:00-11:45: authors will be present for individual discussion
11:45-12:45: authors will be present for discussion with assigned facilitators
Facilitator:
P206
P207
P208
P209
R.G. Scheraga, MD, Cleveland, OH
5’Ectonucleotidase (CD73) Impacts on Radiation-Induced
Immune Changes/S. De Leve, F. Wirsdorfer, F. Cappuccini, M.
Stuschke, V. Jendrossek, Essen, Germany, p.A4929
A Retrospective Cohort Analysis of Anti-Jo Associated Lung
Disease/P.D. Jackson, C. Hutchinson, T. Siddharthan, Portland,
OR, p.A4930
Clinical and Imaging Features of Anti-Aminoacyl-tRNA
Synthetase Antibody-Positive Interstitial Lung Disease/
M. Takahashi, K. Mizumura, T. Shimizu, S. Maruoka, T. Morisawa,
N. Takahashi, Y. Gon, S. Hashimoto, Tokyo, Japan, p.A4931
Hypoxia and Macrophage Differentiation Contribute to
Pulmonary Fibrosis Through Regulation of ADORA2B/
K.M. Philip, H. Karmouty-Quintana, T.W. Mills, N.-Y. Chen, J.
Davies, F. Luo, J. Molina, M.R. Blackburn, Houston, TX, p.A4932
P210
P211
P212
Facilitator:
P213
P214
P215
P216
P217
P218
P219
Facilitator:
P220
P221
Relationship Baseline Fibrosis Score to Lung Function in a
Clinical Trial Population with Idiopathic Pulmonary Fibrosis/
S.M. Humphries, T.G. O’Riordan, J.J. Zhang, S. Bayly, R. Sood, A.
Hayden, D.A. Lynch, Denver, CO, p.A4933
CT-Derived Textural Analysis Score Predicts Physiologic
Progression in IPF/S.M. Humphries, M. Strand, K.R. Flaherty, M.I.
Schwarz, E. Kazerooni, E.J.R. Van Beek, D.A. Lynch, Denver, CO,
p.A4934
Inhibition of Glutamine Metabolism Arrests the Development of
Pulmonary Fibrosis/C.L. Vigeland, Y. Chan-Li, S.L. Collins, A.H.
Hughes, M.-H. Oh, J.D. Powell, M.R. Horton, Baltimore, MD,
p.A4935
M.N. Ballinger, PhD, Columbus, OH
Insights from a Multi-Centre Real Life Experience in Germany
with Nintedanib for the Treatment of Idiopathic Pulmonary
Fibrosis/F. Bonella, M. Kreuter, L. Hagmeyer, C. Neurohr, C.
Keller, M. Kohlhaeufl, J. Muller-Quernheim, K. Milger, A. Prasse,
Essen, Germany, p.A4936
Combination Potential of Pirfenidone and Silymarin for
Treatment of Idiopathic Pulmonary Fibrosis/S. Dasari, R. Alluri,
K.V. Routhu, Hyderabad, India, p.A4937
Aspirin-Triggered Resolvin D1, ATRvD1, Reverts Chronic
Pulmonary Fibrosis in a Murine Model/C.F. Benjamim, R.D.F.
Guilherme, T.D.O. Nogueira, J.S. Neves, C.D.A. Canetti, Rio de
Janeiro, Brazil, p.A4938
A Novel Approach for Fibrocyte Identification in Idiopathic
Pulmonary Fibrosis and Pulmonary Hypertension/P. Heukels, J.
Van Hulst, M. Van Nimwegen, K. Boomars, M. Wijsenbeek, L. Van
Den Toorn, H.C. Hoogsteden, R. Hendriks, M. Kool, B. Van Den
Blink, Rotterdam, Netherlands, p.A4939
Proteomic and Transcriptomic Signatures of Hypoxic Lung
Epithelial Cells Reveal a Central Relationship Between Focal
Adhesion Kinase 1 and Galectin-1 Driving Fibrosis/
J.J. Kathiriya, N. Nakra, J. Nixon, P. Patel, V. Vaghasiya, V. Dave,
Tampa, FL, p.A4940
Resident Memory T Cells Arrest and Reverse Pulmonary
Fibrosis/A.H. Hughes, Y. Chan-Li, C.L. Vigeland, S.L. Collins, M.R.
Horton, Baltimore, MD, p.A4941
Performance Characteristic of Six Minute Walk Test in
Scleroderma Patients with Interstitial Lung Disease/C. Ghattas,
A. Gadre, O.A. Minai, K.B. Highland, Boston, MA, p.A4942
R. Guzy, MD, PhD, Chicago, IL
Beta-Catenin Upregulates Fibrosis Associated Genes Through
mRNA Synthesis and Stabilization in Human Lung-Resident
Mesenchymal Cells/P. Cao, N. Walker, Y. Aoki, S. Mazzoni, L.
Badri, E. Fearon, V. Lama, Ann Arbor, MI, p.A4943
Idiopathic Interstitial Pneumonia with Autoimmune Features:
Clinical Characteristics and Prognosis in a French Cohort/
K. Ahmad, T. Barba, J. Traclet, C. Khouatra, V. Cottin, Bron,
France, p.A4944
ATS 2016 • San Francisco